Clinical Study Results Sanofi Pharma, including Sanofi Genzyme

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country.
This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

Clinical study results Sanofi pharma, including Sanofi Genzyme – Letter H

Generic Name Trade Name Condition Study Code Study Name ACCESS TO STUDY / PROTOCOL Access to results
HDM2/ P53 ANTAGONIST Not Marketed Neoplasm malignant TED12318 NA NCT01636479
HISTAMINE H3 RECEPTOR ANTAGONIST Not Marketed Alzheimer's Disease DRI10734 NA NCT01266525
HUDS6-DM4 MAYTANSINOID LOADED ANTI-CA6 MAB Not Marketed Triple Negative Breast Cancer ACT14884 NA EudraCT: 2016-001962-27
HYDROXYCHLOROQUINE Plaquenil Systemic Lupus Erythematosus EFC12368 NA NCT01551069
HYDROXYCHLOROQUINE Plaquenil Coronavirus Infection EFC16855 NA NCT04333654
HYDROXYCHLOROQUINE Plaquenil Coronavirus Infection EFC16858 NA EudraCT: 2020-001270-29
HYALURONIC ACID WITH LIDOCAINE Derma Gel Extra Facial Wrinkles DGE00105 NA NCT00444626
Hylan G-F 20 Synvisc-One Osteoarthritis EFC12791 NA NCT01618708
Hylan G-F 20 Synvisc-One Osteoarthritis EFC12723 C-SOUND NCT03190369
Hylan G-F 20 Synvisc Osteoarthritis SYNV00704 NA NCT00131352
Hylan G-F 20 Synvisc-One Osteoarthritis SYNV03809 OASIS NCT02389452
Hylan G-F 20 Synvisc-One Osteoarthritis SYNV04910 NA NCT01618708
Hylan G-F 20 Synvisc Osteoarthritis SYNVIL06244 NA NCT01586338

*These study results were previously posted on
**This link replaces the same summary that was previously posted